0.5
Cite Score
SJR: 0.129 / SNIP: 0.140
JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
Volume 15, Issue 1 (2023)
3 2023, 15(1): 61-66 |
Back to browse issues page
History
Received: 2022/03/26 | Accepted: 2023/02/28 | Published: 2023/03/6
Received: 2022/03/26 | Accepted: 2023/02/28 | Published: 2023/03/6
How to cite this article
Keyhani A, Rahnejat A, Dabaghi P, Taghva A, Ebrahimi M, Nezami Asl A. Prevalence of Post-Traumatic Stress Disorder among the Healthcare Workers Involved with COVID-19 Treatment and its Effective Factors in Military Hospitals of Iran. 3 2023; 15 (1) :61-66
URL: http://ijwph.daneshafarand.org/article-3-85506-en.html
URL: http://ijwph.daneshafarand.org/article-3-85506-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Department of Clinical Psychology, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran
2- Department of Psychiatry, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran
3- Medicine Research Center, AJA University of Medical Sciences, Tehran, Iran
2- Department of Psychiatry, Faculty of Medicine, AJA University of Medical Sciences, Tehran, Iran
3- Medicine Research Center, AJA University of Medical Sciences, Tehran, Iran
Abstract (2324 Views)
Aims: Due to the prevalence of COVID-19 and its adverse effects on the mental health of healthcare workers, the present study aimed to investigate the prevalence of post-traumatic stress disorder among healthcare workers involved with COVID-19 treatment and its factors in military hospitals of Iran, Tehran within the first two months of 2021 (fourth peak).
Instruments & Methods: This study is a descriptive cross-sectional study, which was performed within the first two months of 2021 (fourth peak). A total of 356 samples were selected among the healthcare workers in three hospitals in Iran, including Imam Reza (501), Family, and Hajar (503) hospitals, using cluster random sampling method. All samples were interviewed in person. To collect data, a researcher-made demographic information questionnaire, and PTSD Symptom Scale – Interview for DSM-5 (PSS-I-5) were used. Data analysis was performed using SPSS 26 software.
Findings: 85.4% of the healthcare workers had no PTSD, and 14.6% had PTSD. 12.4% of the healthcare workers had intrusion, 14% had avoidance, 21.6% had negative changes in cognition and mood, and 13.2% had arousal.
Conclusion: COVID-19 disease can lead to psychological problems in the frontline HCWs. Therefore, it is necessary that planners and community mental health professionals pay special attention to planning and providing mental health interventions, especially in the field of resilience, to the HCWs of military hospitals and centers that are involved with COVID-19 treatment.
Instruments & Methods: This study is a descriptive cross-sectional study, which was performed within the first two months of 2021 (fourth peak). A total of 356 samples were selected among the healthcare workers in three hospitals in Iran, including Imam Reza (501), Family, and Hajar (503) hospitals, using cluster random sampling method. All samples were interviewed in person. To collect data, a researcher-made demographic information questionnaire, and PTSD Symptom Scale – Interview for DSM-5 (PSS-I-5) were used. Data analysis was performed using SPSS 26 software.
Findings: 85.4% of the healthcare workers had no PTSD, and 14.6% had PTSD. 12.4% of the healthcare workers had intrusion, 14% had avoidance, 21.6% had negative changes in cognition and mood, and 13.2% had arousal.
Conclusion: COVID-19 disease can lead to psychological problems in the frontline HCWs. Therefore, it is necessary that planners and community mental health professionals pay special attention to planning and providing mental health interventions, especially in the field of resilience, to the HCWs of military hospitals and centers that are involved with COVID-19 treatment.